26,043 Shares in Intuitive Surgical, Inc. $ISRG Acquired by Jacobs & Co. CA

Jacobs & Co. CA bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 26,043 shares of the medical equipment provider’s stock, valued at approximately $10,356,000.

Several other hedge funds and other institutional investors have also bought and sold shares of ISRG. Main Street Group LTD bought a new position in shares of Intuitive Surgical in the 1st quarter worth $30,000. Laurel Wealth Advisors LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth $31,000. Vermillion Wealth Management Inc. boosted its position in Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after purchasing an additional 25 shares in the last quarter. Turning Point Benefit Group Inc. grew its stake in Intuitive Surgical by 833.3% in the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. Finally, Motiv8 Investments LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at about $34,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of recent research reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Tuesday, May 19th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research report on Tuesday, June 2nd. BTIG Research reduced their price objective on shares of Intuitive Surgical from $512.00 to $469.00 and set a “buy” rating for the company in a research note on Friday, July 17th. Stifel Nicolaus decreased their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Finally, Bank of America decreased their target price on shares of Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th. Twenty equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $509.02.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $378.81 on Friday. The stock has a market cap of $133.83 billion, a PE ratio of 43.39, a price-to-earnings-growth ratio of 2.74 and a beta of 1.46. The stock has a 50-day moving average of $392.87 and a two-hundred day moving average of $445.78. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same quarter in the previous year, the firm earned $1.81 earnings per share. The company’s revenue was up 18.4% on a year-over-year basis. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the transaction, the executive vice president owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the sale, the senior vice president owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 6,634 shares of company stock valued at $2,796,795 over the last quarter. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.